Skip to main content

Table 5 Cut-off points for four biomarkers associated with cardiovascular risk

From: A randomized clinical trial to determine the efficacy of manufacturers’ recommended doses of omega-3 fatty acids from different sources in facilitating cardiovascular disease risk reduction

Biomarker

Risk condition

Very high risk

High risk

Moderate risk

Low risk

OmegaScore™ (EPA + DPA + DHA)

Sudden death

<4.3

4.3-5.1

5.1-6.1

>6.1

ω-3 Serum Equivalence Score

Heart disease

N/A

<5.1

5.1-7.2

>7.2

EPA + DHA Serum Equivalence Score

Fatal ischemic heart disease

N/A

<3.5

3.5-4.5

>4.5

ω-3 Red Blood Cell Equivalence Score

Myocardial infarction

N/A

<5.2

5.2-8.0

>8.0